TERN logo

Terns Pharmaceuticals, Inc. (TERN) Current Assets

Annual Current Assets:

$362.11M+$94.68M(+35.40%)
December 31, 2024

Summary

  • As of today, TERN annual total current assets is $362.11 million, with the most recent change of +$94.68 million (+35.40%) on December 31, 2024.
  • During the last 3 years, TERN annual current assets has risen by +$195.18 million (+116.92%).
  • TERN annual current assets is now at all-time high.

Performance

TERN Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTERNbalance sheet metrics

Quarterly Current Assets:

$300.30M-$18.66M(-5.85%)
September 30, 2025

Summary

  • As of today, TERN quarterly total current assets is $300.30 million, with the most recent change of -$18.66 million (-5.85%) on September 30, 2025.
  • Over the past year, TERN quarterly current assets has dropped by -$76.21 million (-20.24%).
  • TERN quarterly current assets is now -20.24% below its all-time high of $376.51 million, reached on September 30, 2024.

Performance

TERN Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTERNbalance sheet metrics

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

TERN Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+35.4%-20.2%
3Y3 Years+116.9%+57.6%
5Y5 Years+1529.4%+238.4%

TERN Current Assets Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+116.9%-20.2%+57.6%
5Y5-Yearat high+1529.4%-20.2%+238.4%
All-TimeAll-Timeat high+1529.4%-20.2%+1251.2%

TERN Current Assets History

DateAnnualQuarterly
Sep 2025
-
$300.30M(-5.8%)
Jun 2025
-
$318.95M(-5.6%)
Mar 2025
-
$337.75M(-6.7%)
Dec 2024
$1.82M(+67.7%)
$362.11M(-3.8%)
Sep 2024
-
$376.51M(+63.5%)
Jun 2024
-
$230.24M(-6.4%)
Mar 2024
-
$245.90M(-8.1%)
Dec 2023
$1.08M(-41.1%)
$267.43M(-1.1%)
Sep 2023
-
$270.45M(-6.2%)
Jun 2023
-
$288.31M(-3.8%)
Mar 2023
-
$299.66M(+5.1%)
DateAnnualQuarterly
Dec 2022
$1.84M(+61.5%)
$285.19M(+49.7%)
Sep 2022
-
$190.54M(+33.6%)
Jun 2022
-
$142.60M(-7.5%)
Mar 2022
-
$154.11M(-7.7%)
Dec 2021
$1.14M(-19.8%)
$166.93M(-6.6%)
Sep 2021
-
$178.79M(-4.3%)
Jun 2021
-
$186.87M(-5.6%)
Mar 2021
-
$198.04M(+123.2%)
Dec 2020
$1.42M(-15.4%)
$88.73M(+299.3%)
Dec 2019
$1.68M(+181.9%)
$22.22M
Dec 2018
$596.00K
-

FAQ

  • What is Terns Pharmaceuticals, Inc. annual total current assets?
  • What is the all-time high annual current assets for Terns Pharmaceuticals, Inc.?
  • What is Terns Pharmaceuticals, Inc. annual current assets year-on-year change?
  • What is Terns Pharmaceuticals, Inc. quarterly total current assets?
  • What is the all-time high quarterly current assets for Terns Pharmaceuticals, Inc.?
  • What is Terns Pharmaceuticals, Inc. quarterly current assets year-on-year change?

What is Terns Pharmaceuticals, Inc. annual total current assets?

The current annual current assets of TERN is $362.11M

What is the all-time high annual current assets for Terns Pharmaceuticals, Inc.?

Terns Pharmaceuticals, Inc. all-time high annual total current assets is $362.11M

What is Terns Pharmaceuticals, Inc. annual current assets year-on-year change?

Over the past year, TERN annual total current assets has changed by +$94.68M (+35.40%)

What is Terns Pharmaceuticals, Inc. quarterly total current assets?

The current quarterly current assets of TERN is $300.30M

What is the all-time high quarterly current assets for Terns Pharmaceuticals, Inc.?

Terns Pharmaceuticals, Inc. all-time high quarterly total current assets is $376.51M

What is Terns Pharmaceuticals, Inc. quarterly current assets year-on-year change?

Over the past year, TERN quarterly total current assets has changed by -$76.21M (-20.24%)
On this page